CPD Open Access Visual summary
Open Access Content

How to treat melanoma?

This visual summary, based on NICE guidance, outlines the different management options for the different stages of melanoma.

Go to the profile of OnMedica
OnMedica
Editorial team, Wilmington Healthcare
Published
Like
Page of

Interim treatment regimens during the COVID-19 pandemic1

NHS England has published interim treatment changes1 to allow for greater flexibility in the management of cancer during COVID-19 pandemic to ensure clinicians have additional treatment options through this time.

It give the following recommendations regarding the management of melanoma: 

  • Give oral therapy as first-line treatment for BRAF positive patients in preference to immunotherapy to reduce admission for intravenous therapy.
  • Stop immunotherapy doublet (ipilimumab and nivolumab) and switch to single agent nivolumab or pembrolizumab to reduce toxicity.

Reference

  1. NHS England interim treatment changes during the COVID-19 pandemic. Last updated 12 August 2020.

To download more visual summaries and complete the melanoma CPD course register to OnMedica and then click
'View full content'. 

 

Go to the profile of OnMedica

OnMedica

Editorial team, Wilmington Healthcare

OnMedica is an independent, easy to access on-the-go website for doctors. It provides GPs and specialists with easy to digest and up-to-date, relevant educational content whilst enabling the freedom to share and collaborate in a safe-space to further personal development.
3176 Contributions
57 Followers
1 Following

Comments are disabled

You may also be interested in...